Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
02 févr. 2023 10h20 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (OTCPK: BWVI) ("Psycheceutical" or the "Company"), a bioscience company dedicated to developing cutting-edge brain delivery...
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
26 janv. 2023 12h15 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge treatments for...
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
10 janv. 2023 14h05 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc.(OTCPK: BWVI) ("Psycheceutical" or the "Company"), a bioscience company dedicated to developing cutting-edge brain delivery...
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
29 nov. 2022 11h35 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
18 oct. 2022 10h15 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15
13 sept. 2022 11h15 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc. Enters into Exclusive Option to Acquire Vici Health Sciences
16 août 2022 10h14 HE
|
Psycheceutical Bioscience, Inc.
MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (“Psycheceutical” or the “Company”) (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...